122 related articles for article (PubMed ID: 34917263)
1. Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
Hsu R; Baca Y; Xiu J; Wang R; Bodor JN; Kim C; Khan H; Mamdani H; Nagasaka M; Puri S; Liu SV; Korn WM; Nieva JJ
Oncotarget; 2021 Dec; 12(25):2449-2458. PubMed ID: 34917263
[TBL] [Abstract][Full Text] [Related]
2. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M
Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129
[TBL] [Abstract][Full Text] [Related]
3. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.
Marcinkowski B; Stevanović S; Helman SR; Norberg SM; Serna C; Jin B; Gkitsas N; Kadakia T; Warner A; Davis JL; Rooper L; Hinrichs CS
J Immunother Cancer; 2019 Aug; 7(1):229. PubMed ID: 31455429
[TBL] [Abstract][Full Text] [Related]
4. Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.
Shida A; Fukuyama T; Futawatari N; Ohmiya H; Ichiki Y; Yamashita T; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M; Takahashi Y
World J Gastroenterol; 2020 Jan; 26(4):424-432. PubMed ID: 32063691
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Kita-Kyushu Lung Cancer antigen-1 expression and prognosis of cases with lung squamous cell carcinoma.
Ichiki Y; Fukuyama T; Ohmiya H; Ueno M; Yanagi S; Kanasaki Y; Goto H; Mikami S; Yamazaki H; Nakanishi K; Ishida T
Transl Cancer Res; 2021 Dec; 10(12):5212-5221. PubMed ID: 35116371
[TBL] [Abstract][Full Text] [Related]
6. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen.
Bai R; Yuan C
Aging Dis; 2022 Jul; 13(4):1267-1277. PubMed ID: 35855340
[TBL] [Abstract][Full Text] [Related]
7. Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric Cancer.
Takahashi Y; Fukuyama T; Futawatari N; Ichiki Y; Ohmiya H; Chuman M; Yamashita T; Hiki N; Kumamoto Y; Yamazaki H; Nonoguchi H; Nishi Y; Kobayashi N
Anticancer Res; 2019 Nov; 39(11):6259-6263. PubMed ID: 31704855
[TBL] [Abstract][Full Text] [Related]
8. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.
Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M
World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656
[TBL] [Abstract][Full Text] [Related]
9. Detection of KK-LC-1 Protein, a Cancer/Testis Antigen, in Patients with Breast Cancer.
Kondo Y; Fukuyama T; Yamamura R; Futawatari N; Ichiki Y; Tanaka Y; Nishi Y; Takahashi Y; Yamazaki H; Kobayashi N; Watanabe M
Anticancer Res; 2018 Oct; 38(10):5923-5928. PubMed ID: 30275220
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu Z; You W; Qin J; Dai X; Shen H; Wang X; Wu J
Cell Prolif; 2019 May; 52(3):e12581. PubMed ID: 30895661
[TBL] [Abstract][Full Text] [Related]
11. Detection of Kita-Kyushu Lung Cancer Antigen-1, a Cancer/Testis Antigen, in the Stomach Close to a Cancerous Condition.
Otsuka T; Fukuyama T; Futawatari N; Tahara K; Watanabe M; Ichiki Y; Soeno T; Takahashi Y; Yamazaki H; Fujimori Y; Ohshiro T; Kobayashi N; Kida M; Koizumi W; Kusano C
J Cancer; 2022; 13(14):3526-3532. PubMed ID: 36484013
[No Abstract] [Full Text] [Related]
12. KK-LC-1 may be an effective prognostic biomarker for gastric cancer.
Ji J; Chen J; Wang A; Zhang W; Ju H; Liu Y; Li L
BMC Cancer; 2021 Mar; 21(1):267. PubMed ID: 33711953
[TBL] [Abstract][Full Text] [Related]
13. An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer.
Chen X; Liu F; Yu X; Li L; Yan J; Chen X; Liu Q; Liu B
Eur J Med Chem; 2022 Nov; 241():114617. PubMed ID: 35932567
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
15. Identification of a peptide binding to cancer antigen Kita-kyushu lung cancer antigen 1 from a phage-display library.
Yu X; Yan J; Chen X; Wei J; Yu L; Liu F; Li L; Liu B
Cancer Sci; 2021 Oct; 112(10):4335-4345. PubMed ID: 34387029
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
Fukuyama T; Hanagiri T; Takenoyama M; Ichiki Y; Mizukami M; So T; Sugaya M; So T; Sugio K; Yasumoto K
Cancer Res; 2006 May; 66(9):4922-8. PubMed ID: 16651449
[TBL] [Abstract][Full Text] [Related]
18. Reverse Vaccinology Approach in Constructing a Multi-Epitope Vaccine Against Cancer-Testis Antigens Expressed in Non-Small Cell Lung Cancer.
Herrera LRM
Asian Pac J Cancer Prev; 2021 May; 22(5):1495-1506. PubMed ID: 34048178
[TBL] [Abstract][Full Text] [Related]
19. Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.
Baba T; Shiota H; Kuroda K; Shigematsu Y; Ichiki Y; Uramoto H; Hanagiri T; Tanaka F
Eur J Cardiothorac Surg; 2013 Apr; 43(4):759-64. PubMed ID: 22826471
[TBL] [Abstract][Full Text] [Related]
20. Cancer/testis antigens (CTAs) expression in resected lung cancer.
Jin S; Cao S; Li J; Meng Q; Wang C; Yao L; Lang Y; Cao J; Shen J; Pan B; Hu J; Yu Y
Onco Targets Ther; 2018; 11():4491-4499. PubMed ID: 30122941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
